Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast

Jody Vykoukal1, Yihui Chen1, Mingxin Zuo1

  • 1Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cell Reports. Medicine
|December 17, 2025
PubMed

Insights

Triple-negative breast cancer cells survive by salvaging sphingomyelin and clearing mitochondrial damage via extracellular vesicles. Inhibiting this pathway with eliglustat triggers cell death and slows tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Research

Background:

  • Selective mitochondrial autophagy, or mitophagy, promotes cancer cell survival and progression, particularly in triple-negative breast cancer (TNBC).
  • Understanding metabolic adaptations supporting mitochondrial quality control is crucial for developing novel TNBC therapies.

Purpose of the Study:

  • To investigate metabolic adaptations enabling mitochondrial quality control in TNBC.
  • To identify and target a novel onco-metabolic pathway involving sphingolipid metabolism.

Main Methods:

  • Integrated multi-omics analysis combined with functional experimental validation.
  • Investigation of extracellular sphingomyelin salvaging and extracellular vesicle-mediated mitochondrial clearance.
  • Pharmacological targeting using eliglustat, a glucosylceramide synthase inhibitor.

Main Results:

  • A novel mitochondrial quality control mechanism complementary to mitophagy was identified, involving heightened extracellular sphingomyelin salvaging in TNBC.
  • Extracellular vesicle-mediated clearance of mitochondrial damage was observed.
  • Eliglustat treatment induced ceramide-mediated compensatory mitophagy, leading to cancer cell death in vitro.
  • Eliglustat attenuated tumor growth and prolonged survival in preclinical TNBC models (syngeneic and xenograft).

Conclusions:

  • Aberrant sphingolipid metabolism represents an actionable metabolic vulnerability in TNBC.
  • Targeting this pathway with eliglustat offers a promising therapeutic strategy for TNBC.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.8K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.6K